Jessica MacIntyre, ARNP, NP-C, AOCNP, discusses empowering oncology nurse navigators to refer patients undergoing chemotherapy or radiation therapy to nutrition services.
Jessica MacIntyre, ARNP, NP-C, AOCNP, executive director of Clinical Operations for Sylvester Comprehensive Cancer Center, discusses a nurse-led program designed to initiate early referrals of patients with cancer to nutrition services.
MacIntyre oversees various programs including oncology social work, cancer support services, nurse navigation, cancer survivorship, cancer prevention, and phase I clinical research operations. She recently presented at the 47th Annual Oncology Nursing Society Congress about a navigation nurse-driven protocol, which resulted in early referral and intervention to nutrition services.
Timely referral to support is linked to better outcomes; however, nutrition referrals are not typically made prior to the first appointment with the oncology team. This protocol, MacIntyre explains, sought to overcome that barrier by empowering nurse navigators to make referrals based on specific criteria, including a diagnosis of head and neck, thyroid, or pancreatic cancer, verbalize an interest in a nutrition consult, receiving total parenteral nutrition or enteral nutrition, and/or report unintentional weight loss of: 1% to 2% total body weight in 1 week, 5% of total body weight in 1 month, or at least 7.5% body weight in 3 months.1
Reference
MacIntyre J, Lovan P, Torrents S. Integrating early referrals to oncology nutrition services through the cancer navigation program: the experience at Sylvester Comprehensive Cancer Center (SCCC). Presented at: 47th Annual Oncology Nursing Society Congress; April 27-May 1, 2022; Anaheim, CA. Abstract P360.
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
May 8th 2024Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Verification Nurse Provides ‘Significant Contribution to Patient Safety’ During Chemo Administration
May 1st 2024The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost savings from less drug waste.
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
May 8th 2024Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Verification Nurse Provides ‘Significant Contribution to Patient Safety’ During Chemo Administration
May 1st 2024The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost savings from less drug waste.
Apalutamide/ADT Confers 100% Recurrence-Free Survival in High-Risk Prostate Cancer
TAR-200 Leads to Lasting Responses in BCG-Unresponsive Bladder Cancer
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
Verbal Workflow for Tocilizumab Orders Results in More Timely CRS Intervention
2 Commerce Drive
Cranbury, NJ 08512